Case reportAcyclovir-induced renal failure: Clinical course and histology☆
References (16)
- et al.
Preclinical toxicology studies with acyclovir: acute and subchronic test
Fundam Appl Toxicol
(1983) Preclinical toxicology profile of acyclovir: an overview
Am J Med
(1982)- et al.
Parenteral acyclovir therapy for herpesvirus infections in man
Lancet
(1979) - et al.
Impaired renal function after bolus injections of acyclovir
Lancet
(1983) - et al.
Renal function after acyclovir intravenous injection
Am J Med
(1982) - et al.
Acyclovir tolerance in humans
Am J Med
(1982) - et al.
Sulfonamide crystalluria: a forgotten disease
J Urol
(1970) - et al.
Overview of acyclovir pharmacokinetic disposition in adults and children
Am J Med
(1982)
There are more references available in the full text version of this article.
Cited by (186)
Acyclovir dosing in herpes encephalitis: A scoping review
2024, Journal of the American Pharmacists AssociationValidation of antiviral potential of herbal ethnomedicine
2022, Evidence-Based Validation of Herbal Medicine: Translational Research on BotanicalsA diagnostician's field guide to crystalline nephropathies
2020, Seminars in Diagnostic PathologyCitation Excerpt :Its association with crystal formation in the kidney is reported in the setting of rapid intravenous infusion at high dosages. Acyclovir crystals are birefringent under polarized light, needle-shaped and can be seen in renal tubules and urine.58 Recovery of renal function is expected in most patients with one report showing recovery of renal function to baseline in an average of 6.5 days after discontinuation of acyclovir.58
Nephrotoxicity of Antimicrobials and Antibiotics
2020, Advances in Chronic Kidney DiseaseMedication-Induced Kidney Injury for the Primary Care Pediatrician
2023, Current Treatment Options in Pediatrics
- ☆
This work was supported in part by a grant from the Burroughs Wellcome Company.
Copyright © 1988 Published by Excerpta Medica Inc.